Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFidelity E.m.ld Regulatory News (FEML)

Share Price Information for Fidelity E.m.ld (FEML)

Share Price is delayed by 15 minutes
Get Live Data
1,400.00    -12.00 (-0.85%)
Bid:
1,398.00
Ask:
1,404.00
Spread: 6.00 (0.429%)
Market Cap: £565.34m
FEML Live PriceLast checked at - London Stock Exchange

Intraday Fidelity E.m.ld Share Chart

Net Asset Value(s)

8 Aug 2025 07:55

RNS Number : 5801U
Fidelity Emerging Markets Limited
08 August 2025
 
Fidelity Emerging Markets Limited 
08 August 2025 
  
The Directors of Fidelity Emerging Markets Limited announce the following unaudited estimates as at 07 August 2025:
  
NAV (ex income)
901.44p
NAV (cum income)
928.47p
Total Assets (ex income)
£576.269 million
Total Assets (cum income)
£593.553 million
  
  
Enquiries:  
  
Fidelity Investment International 
Phone + 44 ( 0) 1737 837846 
  
END  
  
Fidelity Emerging Markets Limited 
Source: Fidelity Emerging Markets Limited 
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NAVQVLBBEVLEBBZ
Date   Source Headline
9th Feb 20268:00 amRNSNet Asset Value(s)
6th Feb 20267:55 amRNSNet Asset Value(s)
5th Feb 20265:26 pmPRNTransaction in Own Shares
5th Feb 20261:15 pmRNS-RInitiation from QuotedData
5th Feb 20268:01 amRNSNet Asset Value(s)
4th Feb 20265:12 pmPRNTransaction in Own Shares
4th Feb 20267:48 amRNSNet Asset Value(s)
3rd Feb 20263:52 pmPRNHolding(s) in Company
3rd Feb 20267:46 amRNSNet Asset Value(s)
2nd Feb 20263:22 pmPRNTotal Voting Rights
2nd Feb 20267:53 amRNSNet Asset Value(s)
30th Jan 20265:09 pmPRNTransaction in Own Shares
30th Jan 20267:42 amRNSNet Asset Value(s)
29th Jan 20267:42 amRNSNet Asset Value(s)
28th Jan 20267:48 amRNSNet Asset Value(s)
27th Jan 20267:35 amRNSNet Asset Value(s)
26th Jan 20265:19 pmPRNTransaction in Own Shares
26th Jan 20267:39 amRNSNet Asset Value(s)
23rd Jan 202612:39 pmPRNMonthly Factsheet as at 31 December 2025
23rd Jan 20267:39 amRNSNet Asset Value(s)
22nd Jan 20267:51 amRNSNet Asset Value(s)
21st Jan 20265:18 pmPRNTransaction in Own Shares
21st Jan 20267:50 amRNSNet Asset Value(s)
20th Jan 20265:10 pmPRNTransaction in Own Shares
20th Jan 20267:52 amRNSNet Asset Value(s)
19th Jan 20265:34 pmPRNTransaction in Own Shares
19th Jan 20267:43 amRNSNet Asset Value(s)
16th Jan 20265:10 pmPRNTransaction in Own Shares
16th Jan 20267:39 amRNSNet Asset Value(s)
15th Jan 20265:07 pmPRNTransaction in Own Shares
15th Jan 20267:39 amRNSNet Asset Value(s)
14th Jan 20264:59 pmPRNTransaction in Own Shares
14th Jan 20267:38 amRNSNet Asset Value(s)
13th Jan 20265:58 pmPRNTransaction in Own Shares
13th Jan 20267:42 amRNSNet Asset Value(s)
12th Jan 20265:05 pmPRNTransaction in Own Shares
12th Jan 20267:52 amRNSNet Asset Value(s)
9th Jan 20265:21 pmPRNTransaction in Own Shares
9th Jan 202612:39 pmPRNHolding(s) in Company
9th Jan 20267:38 amRNSNet Asset Value(s)
8th Jan 20265:22 pmPRNTransaction in Own Shares
8th Jan 20267:39 amRNSNet Asset Value(s)
7th Jan 20265:20 pmPRNTransaction in Own Shares
7th Jan 20267:35 amRNSNet Asset Value(s)
6th Jan 20265:06 pmPRNTransaction in Own Shares
6th Jan 20267:40 amRNSNet Asset Value(s)
5th Jan 20267:59 amRNSNet Asset Value(s)
2nd Jan 20265:13 pmPRNTransaction in Own Shares
2nd Jan 20261:51 pmPRNTotal Voting Rights
2nd Jan 20267:49 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.